NFSG
SURF

Newbridge Financial Services Group’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Newbridge Financial Services Group’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-405
Closed -$352 – 1423
2023
Q2 		$352 Hold
405
– – ﹤0.01% 1273
2023
Q1 		$283 Hold
405
– – ﹤0.01% 1343
2022
Q4 		$332 Hold
405
– – ﹤0.01% 1373
2022
Q3 		$0 Hold
405
– – ﹤0.01% 1512
2022
Q2 		$1K Hold
405
– – ﹤0.01% 1331
2022
Q1 		$1K Buy
+405
New +$1.42K ﹤0.01% 1418
2021
Q3 		– Sell
-1,000
Closed -$7K – 1651
2021
Q2 		$7K Buy
1,000
+300
+43% +$2.31K ﹤0.01% 1063
2021
Q1 		$5K Buy
+700
New +$7K ﹤0.01% 1051

Newbridge Financial Services Group's SURF Position: Q3 2023 in Review

Newbridge Financial Services Group sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 405 shares — an estimated $352 sold.

Newbridge Financial Services Group first reported a position in SURF in Q1 2021 and held it in 8 quarters. The position peaked at $7K in Q2 2021. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

  • Newbridge Financial Services Group reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 405 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $352.
  • Newbridge Financial Services Group first reported a position in Surface Oncology, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • Newbridge Financial Services Group's Surface Oncology, Inc. Common Stock position peaked at $7K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Newbridge Financial Services Group's 13F filing for Q3 2023, filed 17 Oct 2023.